Latest Articles
Medicus Pharma Submits Ind Application for PRECISION-E2 Phase 2A Study of Teverelix in Endometriosis in United Arab Emirates - marketscreener.com
Medicus Pharma Submits Ind Application for PRECISION-E2 Phase 2A Study of Teverelix in Endometriosis in United Arab Emirates marketscreener.com
Published: June 11, 2026, 1:52 p.m.
Endometriosis and Fibroids: Expert Explains Advances Giving Women Less Invasive Treatment Options | Newswise - Newswise
Endometriosis and Fibroids: Expert Explains Advances Giving Women Less Invasive Treatment Options | Newswise Newswise
Published: June 11, 2026, 1:30 p.m.
Medicus Pharma files IND for genomics-enabled endometriosis trial in UAE - Yahoo! Finance Canada
Medicus Pharma files IND for genomics-enabled endometriosis trial in UAE Yahoo! Finance Canada
Published: June 11, 2026, 12:50 p.m.
Endometriosis and fibroids: Expert explains advances giving women less invasive treatment options - Mayo Clinic News Network
Endometriosis and fibroids: Expert explains advances giving women less invasive treatment options Mayo Clinic News Network
Published: June 11, 2026, 12:30 p.m.
Oriva appoints Agnès Arbat as CEO as endometriosis drug enters clinic - The Pharma Letter
Oriva appoints Agnès Arbat as CEO as endometriosis drug enters clinic The Pharma Letter
Published: June 11, 2026, 12:10 p.m.
Medicus Pharma submits IND application for endometriosis trial By Investing.com - Investing.com Nigeria
Medicus Pharma submits IND application for endometriosis trial By Investing.com Investing.com Nigeria
Published: June 11, 2026, 11:58 a.m.
Medicus Pharma submits IND application for endometriosis trial - Investing.com
Medicus Pharma submits IND application for endometriosis trial Investing.com
Published: June 11, 2026, 11:55 a.m.
Medicus Pharma submits IND application for endometriosis trial By Investing.com - Investing.com Canada
Medicus Pharma submits IND application for endometriosis trial By Investing.com Investing.com Canada
Published: June 11, 2026, 11:41 a.m.
Medicus Pharma Ltd. Submits IND Application for Innovative PRECISION-E2 Phase 2a Clinical Trial in Endometriosis - Quiver Quantitative
Medicus Pharma Ltd. Submits IND Application for Innovative PRECISION-E2 Phase 2a Clinical Trial in Endometriosis Quiver Quantitative
Published: June 11, 2026, 11:41 a.m.
UAE study uses Emirati genome data to tailor endometriosis treatment - Stock Titan
UAE study uses Emirati genome data to tailor endometriosis treatment Stock Titan
Published: June 11, 2026, 11:30 a.m.
Link copied to clipboard!